Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CVRX NASDAQ:HYPR NASDAQ:RCEL NASDAQ:STRR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVRXCVRx$5.35-6.8%$5.79$4.37▼$11.30$143.32M0.81335,573 shs26,999 shsHYPRHyperfine$1.10-10.2%$1.49$0.76▼$2.22$107.71M1.4704,984 shs864,817 shsRCELAvita Medical$4.71-5.7%$4.29$3.22▼$7.12$145.01M1.86255,945 shs30,641 shsSTRRStar Equity$10.88-0.8%$10.76$8.26▼$11.99$40.26M0.518,055 shs692 shs10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVRXCVRx+1.95%+11.67%+6.69%-26.69%-12.90%HYPRHyperfine-3.94%-9.63%-11.59%+8.93%+59.48%RCELAvita Medical-3.66%+21.07%+19.62%+21.95%-3.29%STRRStar Equity-3.52%+3.18%-2.66%+14.45%+464.05%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVRXCVRx$5.35-6.8%$5.79$4.37▼$11.30$143.32M0.81335,573 shs26,999 shsHYPRHyperfine$1.10-10.2%$1.49$0.76▼$2.22$107.71M1.4704,984 shs864,817 shsRCELAvita Medical$4.71-5.7%$4.29$3.22▼$7.12$145.01M1.86255,945 shs30,641 shsSTRRStar Equity$10.88-0.8%$10.76$8.26▼$11.99$40.26M0.518,055 shs692 shs10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVRXCVRx+1.95%+11.67%+6.69%-26.69%-12.90%HYPRHyperfine-3.94%-9.63%-11.59%+8.93%+59.48%RCELAvita Medical-3.66%+21.07%+19.62%+21.95%-3.29%STRRStar Equity-3.52%+3.18%-2.66%+14.45%+464.05%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCVRXCVRx 2.67Moderate Buy$11.50114.87% UpsideHYPRHyperfine 2.33Hold$1.7862.86% UpsideRCELAvita Medical 2.43Hold$7.2553.83% UpsideSTRRStar Equity 2.20Hold$28.00157.35% UpsideCurrent Analyst Ratings BreakdownLatest STRR, CVRX, RCEL, and HYPR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/30/2026RCELAvita Medical TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy6/24/2026RCELAvita Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/20/2026STRRStar Equity Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/20/2026STRRStar Equity Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/15/2026RCELAvita Medical Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$3.50 ➝ $6.005/13/2026HYPRHyperfine B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/6/2026CVRXCVRx Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/6/2026STRRStar Equity Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/29/2026HYPRHyperfine BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$2.004/21/2026HYPRHyperfine Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/14/2026CVRXCVRx Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$10.00(Data available from 7/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCVRXCVRx$56.65M2.51N/AN/A$1.50 per share3.57HYPRHyperfine$11.40M9.54N/AN/A$0.42 per share2.61RCELAvita Medical$71.61M2.03N/AN/A($0.55) per share-8.57STRRStar Equity$172.16M0.23$0.60 per share17.99$19.12 per share0.57Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCVRXCVRx-$53.31M-$2.02N/AN/AN/A-89.14%-120.76%-48.38%8/4/2026 (Estimated)HYPRHyperfine-$35.57M-$0.41N/AN/AN/A-226.88%-98.83%-67.09%8/12/2026 (Estimated)RCELAvita Medical-$48.59M-$1.57N/AN/AN/A-62.67%N/A-78.92%8/6/2026 (Estimated)STRRStar Equity-$5.92M-$2.63N/A10.46N/A-4.18%-4.04%-2.40%8/6/2026 (Estimated)Latest STRR, CVRX, RCEL, and HYPR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2026Q2 2026CVRXCVRx-$0.52N/AN/AN/A$15.55 millionN/A5/14/2026Q1 2026RCELAvita Medical-$0.35-$0.35N/A-$7.00$18.30 million$19.25 million5/12/2026Q1 2026HYPRHyperfine-$0.09-$0.09N/A-$0.09$3.54 million$3.90 million5/11/2026Q1 2026CVRXCVRx-$0.51-$0.50+$0.01-$0.50$14.49 million$14.77 million5/11/2026Q1 2026STRRStar Equity$0.05-$0.99-$1.04-$1.17$52.57 million$50.06 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCVRXCVRxN/AN/AN/AN/AN/AHYPRHyperfineN/AN/AN/AN/AN/ARCELAvita MedicalN/AN/AN/AN/AN/ASTRRStar EquityN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCVRXCVRx2.0110.208.89HYPRHyperfine0.385.524.90RCELAvita MedicalN/A0.470.38STRRStar Equity0.092.091.84Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCVRXCVRx75.27%HYPRHyperfine15.03%RCELAvita Medical27.66%STRRStar Equity3.84%Insider OwnershipCompanyInsider OwnershipCVRXCVRx18.90%HYPRHyperfine26.33%RCELAvita Medical2.80%STRRStar Equity31.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCVRXCVRx16026.54 million21.52 millionOptionableHYPRHyperfine19099.27 million73.13 millionOptionableRCELAvita Medical13030.78 million29.92 millionOptionableSTRRStar Equity1,2003.70 million2.53 millionNot OptionableSTRR, CVRX, RCEL, and HYPR HeadlinesRecent News About These CompaniesStar Equity Holdings Added to the Russell Microcap® IndexJune 29, 2026 | globenewswire.comInsider Buying: Star Equity (NASDAQ:STRR) CEO Acquires 4,766 Shares of StockJune 24, 2026 | insidertrades.comJeffrey Eberwein Acquires 4,994 Shares of Star Equity (NASDAQ:STRR) StockJune 18, 2026 | insidertrades.comStar Equity (NASDAQ:STRR) CEO Jeffrey Eberwein Purchases 1,884 SharesJune 13, 2026 | insidertrades.comStar Equity (NASDAQ:STRR) CEO Jeffrey Eberwein Purchases 2,849 SharesJune 10, 2026 | insidertrades.comJeffrey Eberwein Purchases 1,430 Shares of Star Equity (NASDAQ:STRR) StockJune 5, 2026 | insidertrades.comStar Equity (NASDAQ:STRR) Director Acquires $11,600.00 in StockJune 3, 2026 | insidertrades.comStar Equity (NASDAQ:STRR) CEO Acquires $17,176.38 in StockJune 2, 2026 | insidertrades.comStar Equity Holdings, Inc. to Present at Noble Capital Markets Emerging Growth Virtual Conference on June 3-4, 2026June 1, 2026 | quiverquant.comQStar Equity Holdings to Present at the Noble Capital Markets Emerging Growth Virtual Conference on June 3-4June 1, 2026 | globenewswire.comStar Equity (NASDAQ:STRR) CEO Buys $26,906.88 in StockMay 28, 2026 | insidertrades.comInsider Stock Buying Reaches US$4.21m On Star Equity HoldingsMay 22, 2026 | finance.yahoo.comInsider Buying: Star Equity (NASDAQ:STRR) CEO Buys 4,198 Shares of StockMay 22, 2026 | insidertrades.comStar Equity Launches ATM Preferred Stock Offering ProgramMay 18, 2026 | tipranks.comStar Equity Declares Cash Dividend on Preferred StockMay 15, 2026 | tipranks.comStar Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred StockMay 15, 2026 | globenewswire.comStar Equity Holdings: Q1 Earnings SnapshotMay 11, 2026 | khou.comKStar Equity Holdings (STRR) Reports Q1 Loss, Misses Revenue EstimatesMay 11, 2026 | zacks.comStar Equity Holdings Reports Strong Q1 Revenue Growth and Achieves $2.6 Million in Merger SynergiesMay 11, 2026 | quiverquant.comQStar Equity Holdings Reports 2026 First Quarter ResultsMay 11, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesMission Control: Floating In SpaceX's Record-Breaking OrbitBy Jeffrey Neal Johnson | June 15, 2026SpaceX Rings the Bell and Shatters Every RecordBy Jeffrey Neal Johnson | June 12, 2026Gravity Check: Houston, SpaceX Has a Valuation ProblemBy Jeffrey Neal Johnson | June 16, 2026These 5 Companies Just Made a Massive Bet on ThemselvesBy Thomas Hughes | June 15, 20263 European Stocks to Carry Investors Through the Back Half of 2026By Chris Markoch | July 1, 2026STRR, CVRX, RCEL, and HYPR Company DescriptionsCVRx NASDAQ:CVRX$5.35 -0.39 (-6.76%) As of 11:29 AM Eastern This is a fair market value price provided by Massive. Learn more.CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.Hyperfine NASDAQ:HYPR$1.10 -0.13 (-10.25%) As of 11:29 AM Eastern This is a fair market value price provided by Massive. Learn more.Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.Avita Medical NASDAQ:RCEL$4.71 -0.29 (-5.74%) As of 11:29 AM Eastern This is a fair market value price provided by Massive. Learn more.AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.Star Equity NASDAQ:STRR$10.88 -0.09 (-0.82%) As of 10:42 AM Eastern This is a fair market value price provided by Massive. Learn more.Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Apple and Broadcom Forge a Decade-Long Silicon Fortress SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity Industrials Are Leading in 2026, But These ETFs Take Different Routes Palantir's CEO Just Called Out OpenAI and Anthropic Drone Stocks Are Down, But Defense Backlogs Tell a Different Story Silicon Starvation: Amazon Feasts on Legacy GPUs Stacking Chips: The Hidden Supply Shock Fueling Intel Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
